Revelation Biosciences (REVB) Earnings Date & Reports

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

REVB is expected to report earnings to rise 1.72% to -88 cents per share on November 05

Revelation Biosciences REVB Stock Earnings Reports

Q3'26

Est.

$-0.88

Q2'26

Missed

by $0.04

Q4'25

Beat

by $8.25

Q3'25

Beat

by $7.83

Q2'25

Beat

by $1.99

The last earnings report on August 07 showed earnings per share of -87 cents, missing the estimate of -82 cents. With 136.03K shares outstanding, the current market capitalization sits at 3.98M.

View a ticker or compare two or three

REVB

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days